Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics (NQ: CORT )

25.34 -0.22 (-0.88%)
Streaming Delayed Price Updated: 3:48 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 361,084
Open 25.59
Bid (Size) 25.33 (3)
Ask (Size) 25.34 (2)
Prev. Close 25.56
Today's Range 25.21 - 25.98
52wk Range 17.86 - 34.27
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In the world of growth stocks, NASDAQ:CORT shines as a value proposition.
Don't overlook NASDAQ:CORT—a stock with solid growth prospects and a reasonable valuation. 
Via Chartmill
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor. 
Via InvestorPlace
Topics Economy
Exposures Economy

Performance

YTD
+25.61%
+25.61%
1 Month
-7.30%
-7.30%
3 Month
-22.92%
-22.92%
6 Month
+7.85%
+7.85%
1 Year
-0.88%
-0.88%

More News

Read More
Where Corcept Therapeutics Stands With Analysts
Via Benzinga
Clorox To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Despite its growth, NASDAQ:CORT remains within the realm of affordability.
Via Chartmill
5 Analysts Have This to Say About Corcept Therapeutics
Via Benzinga
Corcept Appoints Monica Tellado as President, Emerging Markets
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Expert Ratings for Corcept Therapeutics
Via Benzinga
Why Corcept Therapeutics Stock Popped Today
Via Benzinga
Earnings Preview For Corcept Therapeutics
Via Benzinga
Analyst Expectations for Corcept Therapeutics's Future
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
S&P 500 Pullback Update: Are We Nearing The Light At The End Of The Tunnel?
Via Talk Markets
Topics Stocks
Exposures US Equities
Corcept Therapeutics Inc. (NASDAQ: CORT) Sets New 52-Week High in Wednesday Session
Via Investor Brand Network
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
From Corcept Therapeutics Incorporated
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.